TY  - JOUR

T1  - Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome. Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: Serious concerns over the reliability of the PLATO trial, International Journal of Cardiology,

JO  - International Journal of Cardiology

PY  - 2013/01/01

AU  - Wallentin L

AU  - Held C

AU  - James SK

AU  - Becker RC

AU  - Pieper KS

AU  - Cannon CP

AU  - Himmelmann A

AU  - Husted S

AU  - Katus HS

AU  - Mahaffey KW

AU  - Harrington RA et al

ED  - 

DO  - DOI: 10.1016/j.ijcard.2013.11.003

Y2  - 2024/12/28

ER  -